These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30797769)

  • 41. Myeloperoxidase: a potential therapeutic target for coronary artery disease.
    Chaikijurajai T; Tang WHW
    Expert Opin Ther Targets; 2020 Jul; 24(7):695-705. PubMed ID: 32336171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
    Loria V; Dato I; Graziani F; Biasucci LM
    Mediators Inflamm; 2008; 2008():135625. PubMed ID: 18382609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis.
    Zheng W; Warner R; Ruggeri R; Su C; Cortes C; Skoura A; Ward J; Ahn K; Kalgutkar A; Sun D; Maurer TS; Bonin PD; Okerberg C; Bobrowski W; Kawabe T; Zhang Y; Coskran T; Bell S; Kapoor B; Johnson K; Buckbinder L
    J Pharmacol Exp Ther; 2015 May; 353(2):288-98. PubMed ID: 25698787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction.
    Askari AT; Brennan ML; Zhou X; Drinko J; Morehead A; Thomas JD; Topol EJ; Hazen SL; Penn MS
    J Exp Med; 2003 Mar; 197(5):615-24. PubMed ID: 12615902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potentiation of myeloperoxidase activity by the glycosaminoglycan-dependent binding of myeloperoxidase to proteins of the extracellular matrix.
    Kubala L; Kolářová H; Víteček J; Kremserová S; Klinke A; Lau D; Chapman AL; Baldus S; Eiserich JP
    Biochim Biophys Acta; 2013 Oct; 1830(10):4524-36. PubMed ID: 23707661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
    Malle E; Marsche G; Panzenboeck U; Sattler W
    Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.
    Scharnagl H; Kleber ME; Genser B; Kickmaier S; Renner W; Weihrauch G; Grammer T; Rossmann C; Winkelmann BR; Boehm BO; Sattler W; März W; Malle E
    Int J Cardiol; 2014 Jun; 174(1):96-105. PubMed ID: 24746542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uric acid and cardiovascular disease.
    Ndrepepa G
    Clin Chim Acta; 2018 Sep; 484():150-163. PubMed ID: 29803897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gamma-glutamyl transferase and cardiovascular disease.
    Ndrepepa G; Kastrati A
    Ann Transl Med; 2016 Dec; 4(24):481. PubMed ID: 28149843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased nucleotide excision repair in steatotic livers associates with myeloperoxidase-immunoreactivity.
    Schults MA; Nagle PW; Rensen SS; Godschalk RW; Munnia A; Peluso M; Claessen SM; Greve JW; Driessen A; Verdam FJ; Buurman WA; van Schooten FJ; Chiu RK
    Mutat Res; 2012 Aug; 736(1-2):75-81. PubMed ID: 22100520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloperoxidase and coronary arterial disease: from research to clinical practice.
    Roman RM; Wendland AE; Polanczyk CA
    Arq Bras Cardiol; 2008 Jul; 91(1):e11-9. PubMed ID: 18660935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A versatile imaging platform with fluorescence and CT imaging capabilities that detects myeloperoxidase activity and inflammation at different scales.
    Wang C; Pulli B; Jalali Motlagh N; Li A; Wojtkiewicz GR; Schmidt SP; Wu Y; Zeller MWG; Chen JW
    Theranostics; 2019; 9(25):7525-7536. PubMed ID: 31695784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production.
    Haegens A; Heeringa P; van Suylen RJ; Steele C; Aratani Y; O'Donoghue RJ; Mutsaers SE; Mossman BT; Wouters EF; Vernooy JH
    J Immunol; 2009 Jun; 182(12):7990-6. PubMed ID: 19494324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
    Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease.
    Churg A; Marshall CV; Sin DD; Bolton S; Zhou S; Thain K; Cadogan EB; Maltby J; Soars MG; Mallinder PR; Wright JL
    Am J Respir Crit Care Med; 2012 Jan; 185(1):34-43. PubMed ID: 21997333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myeloperoxidase: A new player in autoimmunity.
    Strzepa A; Pritchard KA; Dittel BN
    Cell Immunol; 2017 Jul; 317():1-8. PubMed ID: 28511921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myeloperoxidase and its contributory role in inflammatory vascular disease.
    Lau D; Baldus S
    Pharmacol Ther; 2006 Jul; 111(1):16-26. PubMed ID: 16476484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress.
    Lin W; Chen H; Chen X; Guo C
    Antioxidants (Basel); 2024 Jan; 13(1):. PubMed ID: 38275657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
    Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
    Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.